Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure

BACKGROUND: The aim of this study was to provide new insights into the prevalence of positive antinuclear antibody (ANA) in patients with HBV-related acute-on-chronic liver failure (ACLF) and its impact on clinical outcomes. METHODS: A total of 116 patients with HBV-related ACLF treated at three cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lin, Lin, Bin, Lan, Qing, Liu, Longgen, Lu, Jianchun, Zhang, Xiujun, Zheng, Shuqin, Xue, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881176/
https://www.ncbi.nlm.nih.gov/pubmed/35223685
http://dx.doi.org/10.1155/2022/7981338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881176/
https://www.ncbi.nlm.nih.gov/pubmed/35223685
http://dx.doi.org/10.1155/2022/7981338

Ejemplares similares